ITURBOCAR Trademark

Trademark Overview

On Friday, May 8, 2020, a trademark application was filed for ITURBOCAR with the United States Patent and Trademark Office. The USPTO has given the ITURBOCAR trademark a serial number of 88906315. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, February 26, 2024. This trademark is owned by Allogene Therapeutics, Inc.. The ITURBOCAR trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations, namely, preparations for use in the treatment of cancer and tumors; pharmaceutical and biological preparations for immunotherapy, including T Cell therapy
iturbocar

General Information

Serial Number88906315
Word MarkITURBOCAR
Filing DateFriday, May 8, 2020
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, February 26, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 1, 2020

Trademark Statements

Goods and ServicesPharmaceutical preparations, namely, preparations for use in the treatment of cancer and tumors; pharmaceutical and biological preparations for immunotherapy, including T Cell therapy

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, May 19, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAllogene Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080
Party NameAllogene Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080

Trademark Events

Event DateEvent Description
Monday, February 26, 2024ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, February 26, 2024ABANDONMENT - NO USE STATEMENT FILED
Thursday, August 24, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, August 23, 2023SOU EXTENSION 5 GRANTED
Wednesday, July 26, 2023SOU EXTENSION 5 FILED
Wednesday, August 23, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, August 1, 2023NOTICE OF REVIVAL - E-MAILED
Monday, July 31, 2023SOU EXTENSION RECEIVED WITH TEAS PETITION
Monday, July 31, 2023PETITION TO REVIVE-GRANTED
Monday, July 31, 2023TEAS PETITION TO REVIVE RECEIVED
Saturday, January 21, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, January 19, 2023SOU EXTENSION 4 GRANTED
Thursday, January 19, 2023SOU EXTENSION 4 FILED
Thursday, January 19, 2023SOU TEAS EXTENSION RECEIVED
Thursday, July 21, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, July 19, 2022SOU EXTENSION 3 GRANTED
Tuesday, July 19, 2022SOU EXTENSION 3 FILED
Tuesday, July 19, 2022SOU TEAS EXTENSION RECEIVED
Saturday, December 11, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, December 9, 2021SOU EXTENSION 2 GRANTED
Thursday, December 9, 2021SOU EXTENSION 2 FILED
Thursday, December 9, 2021SOU TEAS EXTENSION RECEIVED
Saturday, May 22, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, May 20, 2021SOU EXTENSION 1 GRANTED
Thursday, May 20, 2021SOU EXTENSION 1 FILED
Thursday, May 20, 2021SOU TEAS EXTENSION RECEIVED
Tuesday, January 26, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, December 1, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 1, 2020PUBLISHED FOR OPPOSITION
Wednesday, November 11, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, October 29, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, October 29, 2020EXAMINER'S AMENDMENT ENTERED
Thursday, October 29, 2020NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, October 29, 2020EXAMINERS AMENDMENT E-MAILED
Thursday, October 29, 2020EXAMINERS AMENDMENT -WRITTEN
Tuesday, August 11, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, August 11, 2020NON-FINAL ACTION E-MAILED
Tuesday, August 11, 2020NON-FINAL ACTION WRITTEN
Wednesday, August 5, 2020ASSIGNED TO EXAMINER
Tuesday, May 19, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, May 12, 2020NEW APPLICATION ENTERED

Related Keywords

iturbocar preparations pharmaceutical including therapy immunotherapy cell tumors namely treatment cancer